Skip to main content

Advertisement

SpringerLink
Log in

Successful treatment of imatinib-induced periorbital edema with a sodium-glucose cotransporter-2 inhibitor

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Druker BJ, Talpaz M, Resta DJ et al (2001) Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 344:1031–1037

    Article  CAS  Google Scholar 

  2. Fraunfelder FW, Solomon J, Druker BJ, Esmaeli B, Kuyl J (2003) Ocular side-effects associated with imatinib mesylate (Gleevec). J Ocul Pharmacol Ther 19:371–375

    Article  CAS  Google Scholar 

  3. Esmaeli B, Prieto VG, Butler CE et al (2002) Severe periorbital edema secondary to STI571 (Gleevec). Cancer 95:881–887

    Article  Google Scholar 

  4. Pietras K, Östman A, Sjöquist M et al (2001) Inhibition of platelet-derived growth factor receptors reduces interstitial hypertension and increases transcapillary transport in tumors. Can Res 61:2929–2934

    CAS  Google Scholar 

  5. Zinman B, Wanner C, Lachin JM et al (2015) Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 373:2117–2128

    Article  CAS  Google Scholar 

  6. McMurray JJV, Solomon SD, Inzucchi SE et al (2019) Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med 381:1995–2008

    Article  CAS  Google Scholar 

  7. Packer M, Anker SD, Butler J et al (2020) Cardiovascular and renal outcomes with empagliflozin in heart failure. N Engl J Med 383:1413–1424

    Article  CAS  Google Scholar 

  8. Chen J, Williams S, Ho S et al (2010) Quantitative PCR tissue expression profiling of the human SGLT2 gene and related family members. Diabetes Therapy 1:57–92

    Article  CAS  Google Scholar 

  9. De Pascalis A, Cianciolo G, Capelli I, Brunori G, La Manna G (2021) SGLT2 inhibitors, sodium and off-target effects: an overview. J Nephrol 34:673–680

    Article  Google Scholar 

  10. Karg MV, Bosch A, Kannenkeril D et al (2018) SGLT-2-inhibition with dapagliflozin reduces tissue sodium content: a randomised controlled trial. Cardiovasc Diabetol 17:5

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Hematology, Department of Medicine, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada

    Benjamin Chin-Yee & Anargyros Xenocostas

  2. Division of Hematology, Department of Medicine, London Health Sciences Centre, London, ON, Canada

    Benjamin Chin-Yee & Anargyros Xenocostas

Authors
  1. Benjamin Chin-Yee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anargyros Xenocostas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anargyros Xenocostas.

Ethics declarations

Ethics approval

All procedures performed were in accordance with the ethical standards of the institution and with the 1975 Helsinki Declaration and its later amendments.

Consent to participate

Informed consent was obtained from the patient for participation in this case report, as well as permission to publish photographs.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chin-Yee, B., Xenocostas, A. Successful treatment of imatinib-induced periorbital edema with a sodium-glucose cotransporter-2 inhibitor. Ann Hematol 101, 1373–1374 (2022). https://doi.org/10.1007/s00277-021-04741-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-021-04741-3

Search

Navigation